A long-standing problem with breast implants, particularly saline implants that are a bit on the larger size, has been their tendency to move around over time, often requiring a breast lift to shore them up. The tiny silk worm is coming to the rescue in the form of a silk-based biodegradable mesh that provides more support than skin alone.
As Colin Stewart reported last week in his "In Your Face" blog, Allergan’s recent purchase of the cosmetic and reconstructive surgery unit of Serica Technologies, SeriScaffold, the above-mentioned silk-based mesh, joins Allergen’s ever-growing product line which includes the Natrelle brand of breast implants, Botox, Juvederm and Latisse, all big favorites among the beautiful.
“Serica’s scaffold biomaterial expertise provides Allergan with a new tissue engineering platform technology for use in tissue regeneration, including breast augmentation, revision and reconstruction and bariatric applications,” said company spokeswoman Caroline Van Hove.
“The technology represents the first silk-based medical device cleared by the FDA. We are always looking for ways to bolster our medical aesthetic franchise, and our acquisition of Serica is another example of our intent to further develop our leadership and expertise in breast aesthetics and reconstruction.”